Home » Topics » BioWorld Science

BioWorld Science
RSS

Glaxo Wellcome to develop Glylorin

Oct. 25, 1996

Absorbent wound dressing cleared for launch in the U.S.

Oct. 25, 1996

Successful completion of Dermagraft pivotal trial

Oct. 25, 1996

VEGF-B, potential angiogenesis stimulant

Oct. 25, 1996

Glaxo Wellcome anesthetic receives European clearance

Oct. 25, 1996

Novel antimigraine agent launched in the U.K.

Oct. 25, 1996

Antimigraine agents with affinity for 5-HT receptors reported by Pierre Fabre

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Neurex broadens clinical program for SNX-111

Oct. 25, 1996

Theratechnologies-Beaufour Ipsen agreement on TH-9506

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...